Anders Olof Wallström

Member of the company's administrative, management or supervisory body

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Nov 16, 2020 – Mar 13, 2024

Anders Olof Wallström reported 10 transactions between Nov 16, 2020 and Mar 13, 2024. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
255.6K SEK
4 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
10
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

5 insiders bought Xbrane Biopharma AB shares worth 780,834 SEK between Jun 1, 2023 and Jun 21, 2023

Cluster buying

5 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Xbrane Biopharma AB shares worth 780,834 SEK between Jun 1, 2023 and Jun 21, 2023
Date Insider Transaction Shares Price Value Filing
Jun 1, 2023 Anette Lindqvist SACQ Acquisition 3,000 78.80 SEK 236,400 SEK FI filing ↗
Jun 13, 2023 Anders Olof Wallström SACQ Acquisition 1,869 80.09 SEK 149,688 SEK FI filing ↗
Jun 13, 2023 Nina Ivers SACQ Acquisition 621 80.00 SEK 49,680 SEK FI filing ↗
Jun 15, 2023 Karl Martin Erik Åmark SACQ Acquisition 1,869 80.09 SEK 149,688 SEK FI filing ↗
Jun 21, 2023 Kirsti Gjellan SACQ Acquisition 2,500 78.15 SEK 195,379 SEK FI filing ↗

Total of the rows above: 780,834 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 10 most recent rows are grouped into 8 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Xbrane Biopharma AB SSUB Subscriptionnot a buy/sell decision 3,479 shares 40.0K SEK at 11.50 SEK FI filing ↗
  2. Xbrane Biopharma AB SEXI Exercise increasenot a buy/sell decision 3,000 shares 673 SEK at 0.22 SEK FI filing ↗
  3. Xbrane Biopharma AB SEXD Exercise decreasenot a buy/sell decisionreported at zero 3,000 shares 0 SEK at 0.00 SEK FI filing ↗
  4. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decisionreported at zero 3,000 shares 0 SEK at 0.00 SEK FI filing ↗
  5. Xbrane Biopharma AB SACQ Acquisition 1,869 shares 149.7K SEK at 80.09 SEK FI filing ↗
  6. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 3,003 shares 206.6K SEK at 68.80 SEK FI filing ↗
  7. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 1,500 shares 251.4K SEK at 167.60 SEK FI filing ↗
  8. Xbrane Biopharma AB SACQ Acquisition × 3 1,500 shares 105.9K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,065 70.60 SEK 75.2K SEK FI filing ↗
    58 70.20 SEK 4.1K SEK FI filing ↗
    377 70.60 SEK 26.6K SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Xbrane Biopharma AB SE0007789409 Xbrane Biopharma AB 10,872 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Anders Olof Wallström reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.